(S (NP (EX There)) (VP (VBZ is) (NP (NP (DT a) (VBG growing) (NN need)) (PP (IN for) (NP (ADJP (JJ fast) (CC and) (JJ accurate)) (NNS methods))) (PP (IN for) (S (VP (VBG testing) (NP (JJ developmental) (NN neurotoxicity)) (PP (IN across) (NP (JJ several) (NN chemical) (NN exposure) (NNS sources)))))))) (. .))
(S (NP (NP (JJ Current) (NNS approaches)) (, ,) (PP (JJ such) (IN as) (NP (NP (ADJP (FW in) (FW vivo)) (NN animal) (NNS studies)) (, ,) (CC and) (NP (NP (NNS assays)) (PP (IN of) (NP (NML (NML (NN animal)) (CC and) (NML (JJ human) (JJ primary) (NN cell))) (NNS cultures)))))) (, ,)) (VP (VB suffer) (PP (IN from) (NP (NP (NNS challenges)) (VP (VBN related) (PP (IN to) (NP (NN time) (, ,) (NN cost) (, ,) (CC and) (NN applicability))) (PP (IN to) (NP (JJ human) (NN physiology))))))) (. .))
(S (NP (PRP We)) (ADVP (RB previously)) (VP (VBD demonstrated) (NP (NN success)) (S (VP (VBG employing) (NP (NN machine) (NN learning)) (S (VP (TO to) (VP (VB predict) (NP (JJ developmental) (NN neurotoxicity)) (S (VP (VBG using) (NP (NP (NN gene) (NN expression) (NNS data)) (VP (VBN collected) (PP (IN from) (NP (NP (JJ human) (NML (NN 3D) (NN tissue)) (NNS models)) (VP (VBN exposed) (PP (IN to) (NP (JJ various) (NNS compounds)))))))))))))))) (. .))
(S (S (NP (DT The) (JJ 3D) (NN model)) (VP (VBZ is) (ADJP (RB biologically) (JJ similar) (PP (IN to) (S (VP (VBG developing) (NP (JJ neural) (NNS structures)))))))) (, ,) (CC but) (S (NP (PRP$ its) (NN complexity)) (VP (VBZ necessitates) (NP (JJ extensive) (NN expertise) (CC and) (NN effort)) (S (VP (TO to) (VP (VB employ)))))) (. .))
(S (PP (IN By) (S (ADVP (RB instead)) (VP (VBG focusing) (ADVP (RB solely)) (PP (IN on) (S (VP (VBG constructing) (NP (NP (DT an) (NN assay)) (PP (IN of) (NP (JJ developmental) (NN neurotoxicity)))))))))) (, ,) (NP (PRP we)) (VP (VBP propose) (SBAR (IN that) (S (NP (DT a) (JJR simpler) (NML (NN 2D) (NN tissue)) (NN model)) (VP (MD may) (VP (VB prove) (ADJP (JJ sufficient))))))) (. .))
(S (NP (PRP We)) (VP (VP (ADVP (RB thus)) (VBP compare) (NP (NP (DT the) (NN accuracy)) (PP (IN of) (NP (NP (JJ predictive) (NNS models)) (VP (VBN trained) (PP (IN on) (NP (NP (NNS data)) (PP (IN from) (NP (DT a) (NML (NN 2D) (NN tissue)) (NN model))))) (PP (IN with) (NP (NP (DT those)) (VP (VBN trained) (PP (IN on) (NP (NP (NNS data)) (PP (IN from) (NP (DT a) (NML (JJ 3D) (NN tissue)) (NN model))))))))))))) (, ,) (CC and) (VP (VB find) (NP (DT the) (NN 2D) (NN model)) (S (VP (TO to) (VP (VB be) (ADJP (RB substantially) (RBR more) (JJ accurate))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (VP (VBP find) (NP (DT the) (NN 2D) (NN model)) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (RBR more) (JJ robust)) (PP (IN under) (NP (JJ stringent) (NN gene) (NN set) (NN selection)))) (, ,) (SBAR (IN whereas) (S (NP (DT the) (JJ 3D) (NN model)) (VP (VBZ suffers) (NP (JJ substantial) (NN accuracy) (NN degradation))))))))) (. .))
(S (SBAR (IN While) (S (NP (DT both) (NNS approaches)) (VP (VBP have) (NP (NNS advantages) (CC and) (NNS disadvantages))))) (, ,) (NP (PRP we)) (VP (VBP propose) (SBAR (IN that) (S (NP (PRP$ our) (ADJP (VBN described)) (NN 2D) (NN approach)) (VP (MD could) (VP (VB be) (NP (NP (DT a) (JJ valuable) (NN tool)) (PP (IN for) (NP (NN decision) (NNS makers)))) (SBAR (WHADVP (WRB when)) (S (VP (VBG prioritizing) (NP (NN neurotoxicity) (NN screening)))))))))) (. .))
